Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026
Feb 24 (Reuters) - SynAct Pharma AB SYNACT.ST: APPOINTS ANN KRISTIN LED AS CFO EFFECTIVE MARCH 2026 Source text: ID:nMFNbMZL2R Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development